Cedarlane pneumococcus antigens

Ended Purchase Order Awarded Last action

Contract number
75D30124P19856
Awardee
Awarding agency
Obligated
$42,948

Award facts

Opportunity
  • 75D30124Q78311 Solicitation number
Contract value 100% obligated
$42,947.87 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Burlington, NC, USA

Award details come from SAM.gov/FPDS.

About this award

The Centers for Disease Control and Prevention awarded a purchase order to Cedarlane Laboratories Usa, Inc. for $42,947.87 on September 1, 2024, for pneumococcus antigens. Work is performed in Burlington, North Carolina. The order carries a firm fixed price and is scheduled for completion by November 1, 2024.

Quick answers

Who was awarded contract 75D30124P19856?

75D30124P19856 was awarded to Cedarlane Laboratories Usa, Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 1, 2024.

How much is contract 75D30124P19856 worth?

The government has obligated $42,948 on 75D30124P19856.

Was contract 75D30124P19856 competed?

The extent of competition for 75D30124P19856 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award